- Summary
- Price Reports
- Price History
- Add To Your Stocklist
- View your Stocklist
- Basic Chart
- Interactive Chart
- Headlines
- Company Snapshot
- Summary Reports
- Free Annual Report
- Estimate Snapshot
- Estimate Report
- Mobile Quote
- Real-Time Quote
- Streaming Quote
|
Biovail | Company Snapshot
-
![]()
-
-
-
Vol:
-
Last Trade:
|
BIOVAIL CORPORATION
BIOVAIL CORPORATION is a specialty pharmaceutical company engaged in the formulation, clinical testing, registration, manufacture and commercialization of pharmaceutical products. The compnay is focused on the develpoment and commercialization of medicines that address unmet medical needs in specialty CNS markets.
|
|
| Symbol: |
BVF |
| Exchange(s): |
New York Stock Exchange, Toronto Stock Exchange |
| Industry: |
Consumer Products (Biotechnology & Pharmaceuticals) |
| 5-Star Rating: |
 |
|
ANNUAL FINANCIALS
|
|
|
Dec 31, 2008
12 Months
us$
|
Dec 31, 2007
12 Months
us$
|
Dec 31, 2006
12 Months
us$
|
3Yr.
Growth
% Change
|
|
Total Revenue ($000):
|
771,917
|
875,816
|
1,096,921
|
-10.32
|
|
Earnings before Interest & Tax ($000):
|
127,922
|
221,012
|
265,706
|
-28.45
|
|
Profit/Loss ($000):
|
199,904
|
195,539
|
211,626
|
-9.33
|
|
Earnings per Share:
|
1.25
|
1.22
|
1.32
|
-5.47
|
|
Total Assets ($000):
|
1,623,565
|
1,782,115
|
2,192,442
|
-5.24
|
|
Dividends Per Share
|
1.50
|
1.50
|
0.50
|
|
|
Return on Com. Equity:
|
16.00
|
15.04
|
16.78
|
|
|
Employees:
|
1,389
|
1,533
|
1,591
|
|
|
|
|
|
Trailing 12 Month Results
|
|
|
12 Months ended
Jun 30, 2009, us$
|
12 Months ended
Jun 30, 2008, us$
|
%Change
|
|
Total Revenue ($000):
|
756,128
|
808,609
|
7.92
|
|
Profit/Loss ($000):
|
231,910
|
64,983
|
317.14
|
|
Earnings per Share:
|
1.47
|
0.40
|
310.93
|
|
Dividends Per Share
|
0.36
|
1.50
|
|
Number of Shares:
|
158,227,990
|
158,715,017
|
|
|
|
|
COMPANY INFORMATION
|
|
Report on Business Magazine Top 1000 Ranking
|
| Profit: 0083 |
Revenue: 0196 |
Assets: 0160 |
|
|
|
| Key Personnel |
| CEO: Bill Wells, C.E.O. |
| CFO: Peggy Mulligan, S.V.P. & Chief Financial Offi |
| HR: Mark Durham, S.V.P. Shared Services |
| |
| Contact Information |
| Address: |
7150 Mississauga Road,
Mississauga,
ON,
L5N 8M5 |
Phone: |
905-286-3000 |
| Fax: |
905-286-3050 |
| Web Address: |
www.biovail.com |
| E-Mail : |
ir@biovail.com |
Investor
Relations: |
Nelson F. Isabel, 905-286-3000 |
| |
| Company Type: |
Public |
Company Status: |
Active |
| Auditors: |
Ernst & Young Llp |
| Transfer Agent: |
Cibc Mellon Trust Company Toronto |
| Incorporation: |
Ontario |
| |
| Securities: |
BVF-N BVF-T
|
|
| |
|
|
| |
|
|
All information on this site is compiled by CTVglobemedia Publishing Inc. from reliable industry sources. While all efforts are made to ensure the accuracy of the information, CTVglobemedia Publishing Inc. and its related entities assume no liability for incorrect, incomplete, or missing information from this site. Past performance is not necessarily indicative of future performance. Prior to making any investment decision, consult with a qualified investment advisor.
Copyright © 2009 CTVglobemedia Publishing Inc. All rights reserved.
|
|
|
